See it - Believe it
Our Touch Glucose Monitoring (TGM™) Technology has been tested with more than 600 patients in clinical- and home settings, proving a stable state-of-the-art performance.
Play Video
GlucoBeamTM
The world's first touch glucose monitoring technology
GlucoBeam is not yet cleared for market by health regulators
GlucoBeam Highlights
- Rechargeable Battery
- Touch Display
- Portable
- Bluetooth & WiFi
- Novel and patented optical system
- Raman spectroscopy system
- Open API
- Advanced data algorithm
How GlucoBeam works
Device Roadmap
*System not yet approved in the US
2009
First system to measure glucose non-invasively *
2009
Critical Depth patent granted
2019
First iteration of GlucoBeam *
2021
Clinical testing totaling 600+ participants
Future
FDA clearance of GlucoBeam
Future
Commercialization of GlucoBeam in the U.S.
Future
Advanced algorithm for improved accuracy
Future
Hand-held form factor
Future
Wearable form factor
Customizable
to fit partner requirements
Our technology offers new, vital information to individuals that are unwilling to use existing measurement devices because of pain, inconvenience and stigma involved. TGM will offer a unique position for Digital health partners and employers in the fast-growing digital health sector and enable them to establish a brand-new access point to vital health information.
